Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Proteostasis Therapeutics- Inc. (PTI)

2.78 -0.07 (-2.46%)

07-16 10:22

Open:

2.84

Pre. Close:

2.85

High:

2.84

Low:

2.78

Volume:

31,226

Market Cap:

100M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

2.878 - 2.894

2.894 - 2.907

Low:

2.731 - 2.753

2.753 - 2.772

Close:

2.816 - 2.85

2.85 - 2.878

Technical analysis  (as of: 2018-07-16 10:08:13 AM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 3.53     One year: 3.78

Support:

Support1: 2.68    Support2: 2.23

Resistance:

Resistance1: 3.02    Resistance2: 3.23

Pivot:

2.85

Moving Averages:

MA(5): 2.85     MA(20): 2.89

MA(100): 4.33     MA(250): 3.48

MACD:

MACD(12,26): -0.26     Signal(12,26,9): -0.33

%K %D:

%K(14,3): 24.68     %D(3): 26.99

RSI:

RSI(14): 34.11

52-Week:

High: 8.61  Low: 1.41  Change(%): -39.0

Average Vol(K):

3-Month: 63113  10-Days 22863

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
PTI has closed above bottom band by 27.3%. Bollinger Bands are 86.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to PTI's normal range. The bands have been in this narrow range for 12 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-06-27T18:47:46-04:00
Translate Bio prices upsized initial public offering

2018-06-25T07:00:00-04:00
Proteostasis Added to the Russell 3000® Index

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

36.08

Shares Float (M)

35.66

% Held by Insiders

1.20

% Held by Institutions

64.50

Shares Short (K)

2164

Shares Short Prior Month (K)

Stock Financials

EPS

-2.070

EPS Est. Current Year

-2.750

EPS Est. Next Year

-2.450

EPS Est. Next Quarter

-0.750

Forward EPS

-2.176

Book Value (p.s.)

1.720

PEG Ratio

Profit Margin

Operating Margin

-1064.18

Return on Assets (ttm)

-70.2

Return on Equity (ttm)

-87.0

Qtrly Rev. Growth

-7.7

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.862

Qtrly Earnings Growth

Operating Cash Flow (M)

-49.08

Levered Free Cash Flow (M)

-29.90

atoplab.com

Valuation

P/E

-1.35

P/E Growth Ratio

-0.02

P/BV

1.63

P/S

530755776.00

P/CF

-2.05

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.